Annual EBIT:
-$280.56M-$48.74M(-21.02%)Summary
- As of today, AXSM annual earnings before interest & taxes is -$280.56 million, with the most recent change of -$48.74 million (-21.02%) on December 31, 2024.
- During the last 3 years, AXSM annual EBIT has fallen by -$155.85 million (-124.98%).
- AXSM annual EBIT is now -15152.91% below its all-time high of -$1.84 million, reached on December 31, 2013.
Performance
AXSM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$47.10M+$9.88M(+17.34%)Summary
- As of today, AXSM quarterly earnings before interest & taxes is -$47.10 million, with the most recent change of +$9.88 million (+17.34%) on June 30, 2025.
- Over the past year, AXSM quarterly EBIT has increased by +$30.95 million (+39.65%).
- AXSM quarterly EBIT is now -2675.92% below its all-time high of -$1.70 million, reached on September 30, 2014.
Performance
AXSM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$239.32M+$30.95M(+11.45%)Summary
- As of today, AXSM TTM earnings before interest & taxes is -$239.32 million, with the most recent change of +$30.95 million (+11.45%) on June 30, 2025.
- Over the past year, AXSM TTM EBIT has increased by +$66.39 million (+21.72%).
- AXSM TTM EBIT is now -14005.15% below its all-time high of -$1.70 million, reached on September 30, 2014.
Performance
AXSM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AXSM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -21.0% | +39.6% | +21.7% |
| 3Y3 Years | -125.0% | -20.2% | -66.8% |
| 5Y5 Years | -318.1% | -164.9% | -146.5% |
AXSM EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -125.0% | at low | -638.9% | +52.1% | -61.8% | +21.9% |
| 5Y | 5-Year | -318.1% | at low | -638.9% | +52.1% | -150.1% | +21.9% |
| All-Time | All-Time | >-9999.0% | at low | -2675.9% | +52.1% | >-9999.0% | +21.9% |
AXSM EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$47.10M(+17.3%) | -$239.32M(+11.5%) |
| Mar 2025 | - | -$56.98M(+21.5%) | -$270.27M(+3.7%) |
| Dec 2024 | -$280.56M(-21.0%) | -$72.62M(-16.0%) | -$280.56M(+8.4%) |
| Sep 2024 | - | -$62.62M(+19.8%) | -$306.22M(-0.2%) |
| Jun 2024 | - | -$78.05M(-16.0%) | -$305.71M(-4.4%) |
| Mar 2024 | - | -$67.28M(+31.5%) | -$292.73M(-26.3%) |
| Dec 2023 | -$231.82M(-28.9%) | -$98.27M(-58.2%) | -$231.82M(-19.8%) |
| Sep 2023 | - | -$62.12M(+4.5%) | -$193.47M(-11.3%) |
| Jun 2023 | - | -$65.06M(-920.7%) | -$173.76M(-17.5%) |
| Mar 2023 | - | -$6.37M(+89.4%) | -$147.88M(+17.8%) |
| Dec 2022 | -$179.80M(-44.2%) | -$59.92M(-41.3%) | -$179.80M(-17.9%) |
| Sep 2022 | - | -$42.41M(-8.2%) | -$152.49M(-6.3%) |
| Jun 2022 | - | -$39.18M(-2.3%) | -$143.49M(-6.2%) |
| Mar 2022 | - | -$38.29M(-17.4%) | -$135.15M(-8.4%) |
| Dec 2021 | -$124.71M(-24.3%) | -$32.61M(+2.4%) | -$124.71M(-4.1%) |
| Sep 2021 | - | -$33.41M(-8.3%) | -$119.79M(-10.1%) |
| Jun 2021 | - | -$30.85M(-10.8%) | -$108.76M(-13.7%) |
| Mar 2021 | - | -$27.84M(-0.6%) | -$95.69M(+4.6%) |
| Dec 2020 | -$100.33M(-49.5%) | -$27.69M(-23.8%) | -$100.33M(-3.4%) |
| Sep 2020 | - | -$22.37M(-25.8%) | -$97.07M(-3.8%) |
| Jun 2020 | - | -$17.78M(+45.3%) | -$93.51M(-4.9%) |
| Mar 2020 | - | -$32.49M(-33.0%) | -$89.18M(-32.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$67.11M(-124.9%) | -$24.43M(-29.9%) | -$67.11M(-29.0%) |
| Sep 2019 | - | -$18.81M(-39.9%) | -$52.03M(-26.2%) |
| Jun 2019 | - | -$13.45M(-29.0%) | -$41.23M(-15.3%) |
| Mar 2019 | - | -$10.42M(-11.5%) | -$35.77M(-19.9%) |
| Dec 2018 | -$29.84M(-8.1%) | -$9.35M(-16.7%) | -$29.84M(-8.2%) |
| Sep 2018 | - | -$8.01M(-0.3%) | -$27.58M(-7.5%) |
| Jun 2018 | - | -$7.99M(-77.9%) | -$25.66M(-5.1%) |
| Mar 2018 | - | -$4.49M(+36.7%) | -$24.42M(+11.5%) |
| Dec 2017 | -$27.60M(-2.0%) | -$7.09M(-16.4%) | -$27.60M(+0.2%) |
| Sep 2017 | - | -$6.09M(+9.8%) | -$27.66M(+3.9%) |
| Jun 2017 | - | -$6.75M(+12.0%) | -$28.78M(+0.3%) |
| Mar 2017 | - | -$7.67M(-7.3%) | -$28.86M(-6.6%) |
| Dec 2016 | -$27.07M(-135.9%) | -$7.15M(+0.8%) | -$27.07M(-6.8%) |
| Sep 2016 | - | -$7.21M(-5.6%) | -$25.35M(-25.7%) |
| Jun 2016 | - | -$6.83M(-16.1%) | -$20.17M(-30.7%) |
| Mar 2016 | - | -$5.88M(-8.3%) | -$15.42M(-33.5%) |
| Dec 2015 | -$11.47M(-109.1%) | -$5.43M(-168.4%) | -$11.55M(-43.2%) |
| Sep 2015 | - | -$2.02M(+2.9%) | -$8.07M(-4.2%) |
| Jun 2015 | - | -$2.08M(-3.6%) | -$7.74M(-36.9%) |
| Mar 2015 | - | -$2.01M(-3.2%) | -$5.66M(-55.2%) |
| Dec 2014 | -$5.49M(-198.4%) | -$1.95M(-14.8%) | -$3.65M(-114.8%) |
| Sep 2014 | - | -$1.70M | -$1.70M |
| Dec 2013 | -$1.84M | - | - |
FAQ
- What is Axsome Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. annual EBIT year-on-year change?
- What is Axsome Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Axsome Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. TTM EBIT year-on-year change?
What is Axsome Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of AXSM is -$280.56M
What is the all-time high annual EBIT for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$1.84M
What is Axsome Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, AXSM annual earnings before interest & taxes has changed by -$48.74M (-21.02%)
What is Axsome Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AXSM is -$47.10M
What is the all-time high quarterly EBIT for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$1.70M
What is Axsome Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, AXSM quarterly earnings before interest & taxes has changed by +$30.95M (+39.65%)
What is Axsome Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AXSM is -$239.32M
What is the all-time high TTM EBIT for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$1.70M
What is Axsome Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, AXSM TTM earnings before interest & taxes has changed by +$66.39M (+21.72%)